Regulatory innovations – Milestones for the Chinese market – IMWITOR® 742, MIGYLOL® 810 N & MIGLYOL® 812 N
The filing of two further dossiers with the Chinese NMPA* represents an outstanding milestone for customers in the Chinese market. From now on, manufacturers and exporters of finished pharmaceutical products can refer to these dossiers in their application documents. Our Regulatory Affairs department will issue your "Letter of Access" on [...]